Clinical Trials in Colorado

Showing 11241-11260 of 18,143 trials

WatchPAT Compared to PSG at 8500'

NCT04249011

Subjects who consent to participate in the research will undergo a simultaneous recording of inlab PSG and WatchPAT200 for comparing the WatchPAT data to PSG at an altitude of 8500'.

Sleep Disorder; Breathing-Related

Itamar-Medical, Israel22 participantsStarted May 2018

Woodland Park, Colorado, United States

COMPLETEDPhase 331 miles

Dasotraline Pediatric Extension Study

NCT02457819

This is an open label 26 week extension study for subjects who completed SEP360-202.

Attention Deficit Hyperactivity Disorder

Sumitomo Pharma America, Inc.237 participantsStarted Jun 2015

Dothan, Alabama, United States • Culver City, California, United States • Wildomar, California, United States +33 more locations

WatchPAT Compared to PSG at 8500'

Dasotraline Pediatric Extension Study

Find Trials by Condition in Colorado

Adaptation of the Diabetes Prevention Program for Primary Care

Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or Nilotinib

Nitric Oxide Inhalation to Treat Sickle Cell Pain Crises

First in Patient Study for PF-06840003 in Malignant Gliomas

Severe ARDS: Generating Evidence

A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants

Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis

Endotracheal Intubation Among the Critically Ill: HEMAIR Pilot Study

A Study to Evaluate a Potassium Normalization Treatment Regimen Including Sodium Zirconium Cyclosilicate (ZS) Among Patients With S-K ≥5.8

Authentic Connections for Nurse Leaders

Belimumab Treatment Holiday and Treatment Re-start Study in Lupus Patients

Frozen Red Blood Cell Transfusions in Trauma Patients

A Study of Obinutuzumab to Evaluate Safety and Tolerability in Hypersensitized Adult Participants With End Stage Renal Disease Awaiting Transplantation

A Safety and Pharmacology Study of Atezolizumab (MPDL3280A) Administered With Obinutuzumab or Tazemetostat in Participants With Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma

Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors

TiLE (Time Lapse Eeva) Clinical Trial

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women